Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients.
about
Does accumulation of advanced glycation end products contribute to the aging phenotype?Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseSimple non-invasive assessment of advanced glycation endproduct accumulationAdvanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateAdvanced glycation end products and oxidative stress in type 2 diabetes mellitus.Role of advanced glycation end products in cardiovascular disease.Glycation products as markers and predictors of the progression of diabetic complications.Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus.Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments.Plasma Levels of Advanced Glycation End Products Are Related to the Clinical Presentation and Angiographic Severity of Symptomatic Lower Extremity Peripheral Arterial Disease.Analysis of advanced glycation end products in the DHS Mind Study.The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML).Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanismsEvolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward.Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.Natural compounds with anti-ageing activity.Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches.Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advanced glycation end products.High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patientsAdvanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide.Advanced Glycation End Products in the Pathogenesis of Psoriasis.Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease.Advanced glycation end products in myocardial reperfusion injury.Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.Linking diabetes and atherosclerosis
P2860
Q24632710-42BF856E-2972-4F60-BB78-B032B16680A9Q26782422-A0192565-4602-4DEE-8945-43E47381236CQ28271097-834FACEE-E2A4-43AF-AC06-9E6536A0FC8AQ33563689-3ED7FA62-995E-4F28-B939-0E2B64BBEFECQ34286094-0DFF6073-37B5-4682-995A-EC4912626B28Q35255473-3BD27935-24BF-4BA4-97FF-F0A7251B3509Q35929112-8A32E0CA-0A10-4227-BF89-E8D9A950A9B7Q36203971-DE2194C2-3D31-47A2-8AF5-CEDF55B3217DQ36203996-A7A42A69-C900-4BC6-A8B7-6CE592C4F71AQ36320068-5645AA0D-49CC-49B4-A7D9-2387499063BEQ36530332-AC7DBE20-9CFA-4FC4-91A7-830BFA1C4FF0Q36593852-0B673635-FF01-4216-8735-ACA81BB4707FQ36600193-FA11CD64-1831-499E-B8DC-6DBDD7E942A1Q36942530-47FD54A5-746A-46F6-9C97-D3D22B25E36AQ37036184-6CA773E8-4CA2-442C-8FBF-08F424997F7DQ37279201-018D386F-7EE2-4980-B24C-E6C8118C54F8Q37321970-E2BD0D7D-36A0-43D2-9530-D99154051CB5Q37636453-964AEA0D-E4E3-4073-AB00-791A57113FA0Q37959165-D05025A7-79C7-4AEF-8CB0-DD75C9157708Q38081119-768C361D-241B-4C1C-B19D-92E47057D555Q38108373-F46BFDE6-7FD2-4304-9FB5-770AD47C2CBAQ38140624-F5C6D9F2-8B51-4DA1-A7A2-3172651908D9Q38140700-0FDFC9BB-62E0-452D-85D7-18AAAD8A387EQ38620860-E7D3FB27-E759-456C-A64E-434245227C6FQ38644274-D37C7606-4BC5-4CD2-848A-5BA065173D09Q39366317-4FC4F176-0DB3-4BBA-9EAF-191275DB6931Q41984177-1D10E9B4-0553-435C-9FD8-9141F8581EDFQ43648217-E2D9BDF3-23CC-42CD-94AC-9011E0E6B585Q46257931-F2506AB9-EB2B-4873-869A-0B5B8FC6E6E9Q46382287-5DD9E413-3E7B-4CCC-8864-C69DC6E9FCA9Q51373390-10881BE1-ACB7-4759-BE31-1FC8BD9DBF2FQ52686161-F50820FD-9853-4E28-AC8E-B204DEB96481Q53129191-1EF2CD27-31C6-4E82-B7F0-169AB49228FAQ57182351-1A122746-6880-4008-AE29-301096E13968
P2860
Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Increased serum concentrations ...... y in type 2 diabetic patients.
@ast
Increased serum concentrations ...... y in type 2 diabetic patients.
@en
type
label
Increased serum concentrations ...... y in type 2 diabetic patients.
@ast
Increased serum concentrations ...... y in type 2 diabetic patients.
@en
prefLabel
Increased serum concentrations ...... y in type 2 diabetic patients.
@ast
Increased serum concentrations ...... y in type 2 diabetic patients.
@en
P2093
P2860
P356
P1433
P1476
Increased serum concentrations ...... y in type 2 diabetic patients.
@en
P2093
P2860
P356
10.1136/HEART.85.1.87
P407
P577
2001-01-01T00:00:00Z